Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fennec Pharmaceuticals (FENC) Treasury Shares (2021 - 2025)

Fennec Pharmaceuticals (FENC) has disclosed Treasury Shares for 5 consecutive years, with $244000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Treasury Shares fell 33.51% year-over-year to $244000.0, compared with a TTM value of $244000.0 through Sep 2025, down 33.51%, and an annual FY2024 reading of $324000.0, up 48.62% over the prior year.
  • Treasury Shares was $244000.0 for Q3 2025 at Fennec Pharmaceuticals, up from $100.0 in the prior quarter.
  • Across five years, Treasury Shares topped out at $589000.0 in Q1 2025 and bottomed at $100.0 in Q2 2025.
  • Average Treasury Shares over 5 years is $225711.8, with a median of $218000.0 recorded in 2023.
  • The sharpest move saw Treasury Shares surged 522.86% in 2023, then tumbled 99.98% in 2025.
  • Year by year, Treasury Shares stood at $55000.0 in 2021, then tumbled by 36.36% to $35000.0 in 2022, then soared by 522.86% to $218000.0 in 2023, then soared by 48.62% to $324000.0 in 2024, then decreased by 24.69% to $244000.0 in 2025.
  • Business Quant data shows Treasury Shares for FENC at $244000.0 in Q3 2025, $100.0 in Q2 2025, and $589000.0 in Q1 2025.